Thanks.
Ms. Gomez, you touched on this point as well. Besides the three major provisions, which would give the minister—if he has the subjective belief that there's a problem with off-label use or with products that are approved for use for animals being used for humans—the ability to exempt products completely, there is this section that says, “The Minister may make the order despite any uncertainty respecting the risk of adverse effects that the use of the drug, including a use other than the intended use, may present.”
What kind of test or provision would you prefer or suggest should be in legislation like this, or do you think that this uncertainty test is appropriate?